Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 5
2005 3
2006 2
2007 1
2008 2
2010 2
2011 4
2012 5
2013 6
2014 6
2015 7
2016 15
2017 6
2018 8
2019 5
2020 13
2021 14
2022 10
2023 13
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.
Gerhardt F, Fiessler E, Olsson KM, Kayser MZ, Kovacs G, Gall H, Ghofrani HA, Badr Eslam R, Lang IM, Benjamin N, Grünig E, Halank M, Lange TJ, Ulrich S, Leuchte H, Held M, Klose H, Ewert R, Wilkens H, Pizarro C, Skowasch D, Wissmüller M, Hellmich M, Olschewski H, Hoeper MM, Rosenkranz S. Gerhardt F, et al. Among authors: wilkens h. Circulation. 2024 Apr 12. doi: 10.1161/CIRCULATIONAHA.122.063821. Online ahead of print. Circulation. 2024. PMID: 38606558
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Ghofrani HA, Simonneau G, D'Armini AM, Fedullo P, Howard LS, Jaïs X, Jenkins DP, Jing ZC, Madani MM, Martin N, Mayer E, Papadakis K, Richard D, Kim NH; MERIT study investigators. Ghofrani HA, et al. Lancet Respir Med. 2024 Apr;12(4):e21-e30. doi: 10.1016/S2213-2600(24)00027-4. Lancet Respir Med. 2024. PMID: 38548406 Clinical Trial.
[Chronic thromboembolic pulmonary hypertension].
Guth S, Wilkens H, Halank M, Held M, Hobohm L, Konstantinides S, Omlor A, Seyfarth HJ, Schäfers HJ, Mayer E, Wiedenroth CB. Guth S, et al. Among authors: wilkens h. Pneumologie. 2023 Nov;77(11):937-946. doi: 10.1055/a-2145-4807. Epub 2023 Nov 14. Pneumologie. 2023. PMID: 37963483 Free article. German.
[Chronic thromboembolic pulmonary hypertension].
Adameit MSD, Wiedenroth CB, Omlor A, Schäfers HJ, Guth S, Wilkens H. Adameit MSD, et al. Among authors: wilkens h. Dtsch Med Wochenschr. 2023 Nov;148(23):1514-1523. doi: 10.1055/a-2012-0899. Epub 2023 Nov 10. Dtsch Med Wochenschr. 2023. PMID: 37949080 German.
[Pulmonary hypertension - The new ESC guideline].
Held M, Wilkens H. Held M, et al. Among authors: wilkens h. Dtsch Med Wochenschr. 2023 Nov;148(22):1448-1455. doi: 10.1055/a-1966-9703. Epub 2023 Nov 2. Dtsch Med Wochenschr. 2023. PMID: 37918430 German.
Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis.
Mavromanoli AC, Jiménez D, Sanchez O, Sobkowicz B, Vanni S, Kurzyna M, Becattini C, Pruszczyk P, Wilkens H, Bova C, Tschöpe C, Sawicka-Śmiarowska E, Grifoni C, Kostrubiec M, Torbicki A, Meneveau N, Kresoja KP, Konstantinides SV. Mavromanoli AC, et al. Among authors: wilkens h. Thromb Res. 2023 Nov;231:29-31. doi: 10.1016/j.thromres.2023.09.009. Epub 2023 Sep 28. Thromb Res. 2023. PMID: 37778058 No abstract available.
118 results